The annual per-patient cost for kidney transplant recipients dropped from $33,040 in 2007 to $18,746 in 2011.
Cytomegalovirus viremia less likely with 200 rather than 100 days of valganciclovir after kidney transplantation.
Study characterizes cytomegalovirus infections in a large population of kidney transplant recipients.
In a study, vitamin D and calcium supplementation for one year made no difference in bone mineral density.
At-risk transplant recipients, however, have a lower risk of graft failure with prophylaxis than preemptive therapy.
Right internal jugular vein placement should be used preferentially in TDC to maximize catheter survival.
Ergocalciferol treatment of vitamin D deficiency in HD patients with type 2 diabetes is associated with a significant reduction in the risk of VAD.
Appointment wait time decreased and number of patients seen per month increased.
The trend is most pronounced among Medicare recipients since the debut of bundling, ESA labeling changes.
Researchers recommend BK virus screening for all kidney transplant recipients.
Study implicates low diastolic and high systolic pressure immediately after kidney transplantation.
Combined with use of a binder, this approach raised serum albumin while maintaining target phosphorus levels.
Five-year mortality is lower among PCa patients who receive a transplant rather than stay on dialysis.
Study also showed an increase in the proportion of patients with hemoglobin level below 10 g/dL and in transfusion rates.
In a study, patients seen by a nephrologist were younger, more likely to be women, and had more comorbidities.
Taiwan study finds a twofold increased risk of upper urinary tract stones in patients suffering from urinary incontinence.
Routine screening for bladder cancer may be warranted in this patient population.
Compared with radical nephrectomy, nephron-sparing surgery shift serum creatinine downward.
Shared decision-making about screening recommended for men aged 55-69 years.
Highest intake was associated with a 46% decreased progression risk compared with the lowest intake.
Study found a 27.3% incidence in Caucasians versus 15.5% and 15.1% in African Americans and Hispanics, respectively.
Median survival time from diagnosis improved by a median of 43 months from the pre-PSA to the post-PSA era.
SWL is an independent risk factor for hypertension in patients without CKD.
The incidence of emergency department visits rose 36% from 2007 to 2010 in California.
Study demonstrates improved disease-specific and overall survival.
In fact, men on testosterone replacement therapy (TRT) had a lower PCa rate than men not on TRT.
Data support prophylactic use of a PDE-5 inhibitor in men receiving radiotherapy for prostate cancer.
This approach can reduce adverse events without impairing efficacy.
Collagenase injections decrease penile curvature and eases symptom bother, data show.
Many men even experience an improvement in lower urinary tract symptoms.